Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

The Standards for the Diagnosis and Treatment of Patients with COPD document 2004 updates the position papers on chronic obstructive pulmonary disease (COPD) published by the American Thoracic Society (ATS) and the European Respiratory Society (ERS) in 1995 1, 2. Both societies felt the need to update the previous documents due to the following. 1) The prevalence and overall importance of COPD as a health problem is increasing. 2) There have been enough advances in the field to require an update, especially adapted to the particular needs of the ATS/ERS constituency. 3) It allows for the creation of a “live” modular document based on the web; it should provide healthcare professionals and patients with a user friendly and reliable authoritative source of information. 4) The care of COPD should be comprehensive, is often multidisciplinary and rapidly changing. 5) Both the ATS and the ERS acknowledge the recent dissemination of the Global Initiative of Obstructive Lung Disease (GOLD) 3 as a major worldwide contribution to the battle against COPD. However, some specific requirements of the members of both societies require adaptation of the broad GOLD initiative. Those requirements include specific recommendations on oxygen therapy, pulmonary rehabilitation, noninvasive ventilation, surgery in and for COPD, sleep, air travel, and end-of-life. In addition, special emphasis has been placed on issues related to the habit of smoking and its control. ### Goals and objectives The main goals of the updated document are to improve the quality of care provided to patients with COPD and to develop the project using a disease-oriented approach. To achieve these goals, both organisations have developed a modular electronic web-based document with two components. 1) A component for health professionals that intends to: raise awareness of COPD; inform on the latest advances in the overall pathogenesis, diagnosis, monitoring and management of COPD; and …

[1]  F. Martinez,et al.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  P. Calverley,et al.  Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease , 2003, European Respiratory Journal.

[3]  R. Zuwallack,et al.  Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. , 2003, Chest.

[4]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[5]  I. Stiell,et al.  Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. , 2003, The New England journal of medicine.

[6]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[7]  R. Pauwels,et al.  Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.

[8]  E. Wouters,et al.  Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. , 2003, Nutrition (Burbank, Los Angeles County, Calif.).

[9]  J. Wedzicha,et al.  Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[10]  R. Sansores,et al.  Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[11]  J. Samet,et al.  Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. , 2003, American journal of respiratory and critical care medicine.

[12]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[13]  M. Antonelli,et al.  Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial , 2002, Intensive Care Medicine.

[14]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[15]  O. Sánchez,et al.  Maintaining oxygenation via demand oxygen delivery during rest and exercise. , 2002, Respiratory care.

[16]  B. Tiep,et al.  Using a reservoir nasal cannula in acute care. , 2002, Critical care nurse.

[17]  Toru Oga,et al.  Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. , 2002, Chest.

[18]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[19]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[20]  William Henderson,et al.  Development and Validation of a Multifactorial Risk Index for Predicting Postoperative Pneumonia after Major Noncardiac Surgery , 2001, Annals of Internal Medicine.

[21]  B. Celli,et al.  Postoperative pulmonary complications. , 2001, The Medical clinics of North America.

[22]  R. Dahl,et al.  Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[23]  D. O’Donnell,et al.  Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[24]  M. Elliott,et al.  Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.

[25]  R. Zuwallack,et al.  Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.

[26]  I. Weisman.  Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery. , 2001, Seminars in thoracic and cardiovascular surgery.

[27]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[28]  December,et al.  International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. , 2001 .

[29]  J. Connett,et al.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[30]  M. Fiore.  US public health service clinical practice guideline: treating tobacco use and dependence. , 2000, Respiratory care.

[31]  R. Stockley,et al.  Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care , 2000, Thorax.

[32]  J. Wedzicha.  The heterogeneity of chronic obstructive pulmonary disease , 2000, Thorax.

[33]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[34]  C. C. Christensen,et al.  Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude. , 2000, The European respiratory journal.

[35]  E. Prescott.  Tobacco-related diseases: the role of gender. An epidemiologic study based on data from the Copenhagen Centre for Prospective Population Studies. , 2000, Danish medical bulletin.

[36]  S. Willsie,et al.  Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. , 2000, Respiratory care.

[37]  M. Niederman,et al.  Acute exacerbation of COPD: factors associated with poor treatment outcome. , 2000, Chest.

[38]  tefan,et al.  LONG-TERM TREATMENT WITH INHALED BUDESONIDE IN PERSONS WITH MILD CHRONIC OBSTRUCTIVE PULMONARY DISEASE WHO CONTINUE SMOKING , 2000 .

[39]  J. Vestbo,et al.  Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[40]  S. Rennard.  Inflammation and repair processes in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[41]  E. Emanuel,et al.  Assistance from family members, friends, paid care givers, and volunteers in the care of terminally ill patients. , 1999, The New England journal of medicine.

[42]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[43]  D. O’Donnell,et al.  Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[44]  F. Martinez.  Surgical Therapy for Chronic Obstructive Pulmonary Disease: Conventional Bullectomy and Lung Volume Reduction Surgery in the Absence of Giant Bullae , 1999 .

[45]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[46]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[47]  V. Peinado,et al.  Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[48]  G. Smetana.  Preoperative pulmonary evaluation. , 1999, The New England journal of medicine.

[49]  J. Wedzicha,et al.  An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. , 1999, Respiratory medicine.

[50]  J. Wilson,et al.  Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. , 1999, Chest.

[51]  R. Zuwallack,et al.  Pulmonary rehabilitation - 1999 , 1999 .

[52]  B. Celli.  Pathophysiology of chronic obstructive pulmonary disease. , 1998, Respiratory care clinics of North America.

[53]  M. Estenne,et al.  International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[54]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[55]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .

[56]  J Zieliński,et al.  Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. , 1998, Chest.

[57]  C. Bolliger,et al.  Functional evaluation of the lung resection candidate. , 1998, The European respiratory journal.

[58]  M. Ferrer,et al.  Chronic Obstructive Pulmonary Disease Stage and Health-Related Quality of Life , 1997, Annals of Internal Medicine.

[59]  J. Roca,et al.  Effects of noninvasive ventilation on pulmonary gas exchange and hemodynamics during acute hypercapnic exacerbations of chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[60]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[61]  D. Górecka,et al.  Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.

[62]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[63]  J. Heffner,et al.  Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.

[64]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[65]  D. Dockery,et al.  Effects of cigarette smoking on lung function in adolescent boys and girls. , 1996, The New England journal of medicine.

[66]  J. Crowley,et al.  Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.

[67]  N. Christakis,et al.  Survival of Medicare patients after enrollment in hospice programs. , 1996, The New England journal of medicine.

[68]  Louis Sherwood,et al.  From Outcomes Research to Disease Management: A Guide for the Perplexed , 1996, Annals of Internal Medicine.

[69]  C. Bolliger,et al.  Pulmonary function and exercise capacity after lung resection. , 1996, The European respiratory journal.

[70]  M. Belman,et al.  Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[71]  W. McNicholas,et al.  Ventilation and gas exchange during sleep and exercise in severe COPD. , 1996, Chest.

[72]  G. Snider,et al.  Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema. , 1996, Chest.

[73]  D. Postma,et al.  A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD. A follow-up of 18 months. , 1996, Chest.

[74]  Harvey I. Pass,et al.  Lung cancer : principles and practice , 1996 .

[75]  G. Koëter,et al.  Effects of home rehabilitation on physical performance in patients with chronic obstructive pulmonary disease (COPD). , 1996, The European respiratory journal.

[76]  C. Roussos,et al.  The load of inspiratory muscles in patients needing mechanical ventilation. , 1995, American journal of respiratory and critical care medicine.

[77]  E. Wouters,et al.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.

[78]  J C Yernault,et al.  Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.

[79]  A. Ries,et al.  Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995, Annals of Internal Medicine.

[80]  A. Chaouat,et al.  Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. , 1995, Chest.

[81]  R. Kaplan,et al.  Annals of Internal Medicine Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease , 1995 .

[82]  G. Guyatt,et al.  Randomised controlled trial of respiratory rehabilitation , 1994, The Lancet.

[83]  A. Buist,et al.  In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial , 1994 .

[84]  R. Zuwallack,et al.  The effect of comprehensive outpatient pulmonary rehabilitation on dyspnea. , 1994, Chest.

[85]  In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group. , 1994, Chest.

[86]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[87]  R. Cydulka,et al.  Evaluation of high-yield criteria for chest radiography in acute exacerbation of chronic obstructive pulmonary disease. , 1993, Annals of emergency medicine.

[88]  E. Fletcher,et al.  A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. , 1992, The American review of respiratory disease.

[89]  B. Berg,et al.  Oxygen supplementation during air travel in patients with chronic obstructive lung disease. , 1992, Chest.

[90]  W. O'Donohue.  Effect of oxygen therapy on increasing arterial oxygen tension in hypoxemic patients with stable chronic obstructive pulmonary disease while breathing ambient air. , 1991, Chest.

[91]  J. Bates,et al.  Animals in medical research. Official statement of the American Thoracic Society. , 1991, The American review of respiratory disease.

[92]  M. Lebowitz,et al.  Epidemiology of chronic obstructive pulmonary disease. , 1990, Clinics in chest medicine.

[93]  P. Paré,et al.  The changes in airways structure associated with reduced forced expiratory volume in one second. , 1989, The European respiratory journal.

[94]  B. Berg,et al.  Hypoxemia during air travel in patients with chronic obstructive pulmonary disease. , 1989, Annals of internal medicine.

[95]  S. Quan,et al.  Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. , 1987, Chest.

[96]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[97]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[98]  E. Weitzenblum,et al.  Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. , 1985, The American review of respiratory disease.

[99]  D. Tashkin,et al.  Hypoxia-altitude simulation test: evaluation of patients with chronic airway obstruction , 1984 .

[100]  D. Hudgel,et al.  Contribution of hypoventilation to sleep oxygen desaturation in chronic obstructive pulmonary disease. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[101]  A. Med Assoc Comm Energ Med Serv,et al.  Medical aspects of transportation aboard commercial aircraft , 1982 .

[102]  G. Birnbaum.  Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency: Algert RK, Martin TR, Lewis SW, Ann Intern Med 92:753–758, (Jun) 1980 , 1981 .

[103]  M. Aubier,et al.  Effects of the Administration of O2 on Ventilation and Blood Gases in Patients with Chronic Obstructive Pulmonary Disease During Acute Respiratory Failure1–3 , 2015 .

[104]  R. Albert,et al.  Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. , 1980, Annals of internal medicine.

[105]  Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. , 1980, Annals of internal medicine.

[106]  G. Little,et al.  The natural history of chronic bronchitis and emphysema , 1979 .

[107]  P. Wright,et al.  The Natural History of Chronic Bronchitis and Emphysema , 1977 .

[108]  C. Fletcher.  The Natural history of chronic bronchitis and emphysema: An eight-year study of early chronic obstructive lung disease in working men in London , 1976 .

[109]  H. Thompson,et al.  Prognosis in chronic obstructive pulmonary disease. , 1973, The American review of respiratory disease.

[110]  Report of the Medical Research Council , 1936 .